Bacterial cells are surrounded by a cell wall composed of layers of peptidoglycan (PG). This mesh-like macromolecule stabilizes cell membranes against high internal osmotic pressures and is essential for survival. Peptidoglycan is assembled from the lipid-linked disaccharide pentapeptide precursor Lipid II (Figure [1](#fig1){ref-type="fig"}a, **1**).^[@ref1]^ Peptidoglycan glycosyltransferases polymerize Lipid II into glycan strands and enzymes known as penicillin-binding proteins (PBPs) cross-link and process the peptide side chains to produce mature PG.^[@ref2]^ Because PG is highly conserved and essential for cell survival, it is a target for antibiotics. Indeed, the most successful class of antibiotics in history, the β-lactams, inhibits the transpeptidases (TPs) that cross-link the carbohydrate strands of PG.^[@ref3]^

![Reactions catalyzed by transpeptidases (TPs) that cross-link peptidoglycan. (a) Structures of Lipid II used by *E. coli* and *B. subtilis*.^[@ref4]^ (b) Reactions catalyzed by TPs proceed via an enzyme--substrate intermediate that can be resolved by water to generate a tetrapeptide side chain, by a side chain on another glycan strand to yield a cross-link, or by a [d]{.smallcaps}-amino acid to give a pentapeptide with a new terminal amino acid.](ja-2014-05668f_0001){#fig1}

TPs contain a conserved active-site serine that attacks the terminal [d]{.smallcaps}-Ala-[d]{.smallcaps}-Ala amide bond of the pentapeptide attached to the glycan polymer, forming a covalent enzyme--substrate (E-S) intermediate and releasing [d]{.smallcaps}-Ala (Figure [1](#fig1){ref-type="fig"}b, activation step). An amino group on the peptide side chain of another glycan strand can then attack the E-S intermediate to form a cross-link and regenerate the enzyme (Figure [1](#fig1){ref-type="fig"}b, cross-linking step). While the structure of Lipid II is highly conserved, the identity of the amino acid containing the reactive amino group varies by species.^[@cit1a],[@ref5]^ As the Lipid II substrate is difficult to obtain,^[@ref6],[@ref7]^ it is not well understood how these differences in the stem peptide affect TP cross-linking chemistry.^[@ref8],[@ref9]^

The canonical Lipid II used by Gram-negative bacteria, including *Escherichia coli*, contains the pentapeptide [l]{.smallcaps}-Ala-γ-[d]{.smallcaps}-Glu-*m*-DAP-[d]{.smallcaps}-Ala-[d]{.smallcaps}-Ala (**1**).^[@ref10]^ The third residue, *m*-DAP, which functions as the nucleophile in the cross-linking reaction, has a [d]{.smallcaps}-stereocenter in the side chain. *Bacillus subtilis* Lipid II is similar but contains a carboxamide instead of a carboxylic acid on the *m*-DAP side chain (**2**).^[@ref11],[@ref12]^ Cell wall precursor **1** has been synthesized previously.^[@cit8d]^ We synthesized the *B. subtilis* Lipid II substrate **2** in 32 steps by adapting the synthesis of Gram-negative Lipid II^[@cit8d],[@ref13]^ to introduce the carboxamide-containing *m*-DAP residue.^[@ref14]^

Access to both **1** and **2** has allowed us to investigate the substrate preferences of TPs from *E. coli* and *B. subtilis*. *E. coli* PBP1A and *B. subtilis* PBP1^[@ref15]^ were purified as described in the [Supporting Information](#notes-1){ref-type="notes"}, and each enzyme was then incubated with substrate **1** or substrate **2**. These enzymes contain an N-terminal glycosyltransferase domain that polymerizes disaccharide subunits and a C-terminal TP domain that cross-links polymeric glycan strands. To assess cross-linking, we treated reaction mixtures with the glycosylhydrolase mutanolysin followed by NaBH~4~ and then used LC/MS to identify the products (Figure [2](#fig2){ref-type="fig"}a).^[@cit8d],[@ref16]^ As expected, each enzyme is able to polymerize and cross-link its native substrate (Figure [2](#fig2){ref-type="fig"}b, traces i and ii). In addition, *B. subtilis* PBP1 is able to cross-link the canonical Gram-negative Lipid II (**1**, Figure [2](#fig2){ref-type="fig"}b, trace iii), but *E. coli* PBP1A is not able to cross-link *B. subtilis* Lipid II (**2**, Figure [2](#fig2){ref-type="fig"}b, trace iv), implying that the *E. coli* PBP discriminates against the carboxamide on the *m*-DAP.

![*B. subtilis* transpeptidases (TPs) can cross-link amidated peptidoglycan precursors in vitro. (a) Protocol for detecting cross-linking by *E. coli* and *B. subtilis* TPs in vitro. Fragments A/A′ are derived from unmodified polymer; the remaining products are derived from polymer that has been acted on by a TP. (b) LC/MS-extracted ion chromatograms showing unprocessed (A/A′), hydrolyzed (B/B′), and cross-linked products (C/C′, D/D′) formed in the presence of *E. coli* PBP1A (i,iv) or *B. subtilis* PBP1 (ii,iii) and substrate **1** (i,iii) or **2** (ii,iv).](ja-2014-05668f_0002){#fig2}

We have previously shown that *E. coli* PBP1A can exchange the terminal [d]{.smallcaps}-Ala in cell wall precursors with other [d]{.smallcaps}-amino acids during in vitro PG synthesis.^[@cit13a],[@ref16],[@ref17]^ To further assess the substrate scope of the *E. coli* and *B. subtilis* enzymes, we examined their ability to incorporate either [d]{.smallcaps}-Phe or [d]{.smallcaps}-Phe carboxamide ([d]{.smallcaps}-Phe-NH~2~) into synthetic PG (Figure [3](#fig3){ref-type="fig"}a). *E. coli* PBP1A incorporated [d]{.smallcaps}-Phe but not [d]{.smallcaps}-Phe-NH~2~ (Figure [3](#fig3){ref-type="fig"}b, traces i and ii), whereas *B. subtilis* PBP1 incorporated both (Figure [3](#fig3){ref-type="fig"}b, traces iii and iv).^[@ref18]^ Hence, the cross-linking and [d]{.smallcaps}-amino acid incorporation experiments are consistent in showing that the *E. coli* PBP1A TP domain discriminates against carboxamide substrates but the *B. subtilis* PBP1 TP domain does not.

![*B. subtilis* TPs can incorporate [d]{.smallcaps}-amino carboxamides into PG in vitro. (a) Protocol for detecting TP-mediated [d]{.smallcaps}-amino acid or carboxamide exchange in vitro. (b) LC/MS-extracted ion chromatograms of products generated by reaction of *E. coli* PBP1A (i,ii) or *B. subtilis* PBP1 (iii,iv) with Lipid II and 1 mM [d]{.smallcaps}-Phe (i,iii) or [d]{.smallcaps}-Phe-NH~2~ (ii,iv). Products E/E′ contain [d]{.smallcaps}-Phe; product F′ contains [d]{.smallcaps}-Phe-NH~2~.](ja-2014-05668f_0003){#fig3}

A variety of [d]{.smallcaps}-amino acid probes have recently been developed to fluorescently label PG in living cells,^[@ref19]^ but labeling is poor in *B. subtilis* unless the cell wall hydrolase DacA, which removes terminal [d]{.smallcaps}-amino acids from PG, is absent.^[@cit19a]^ To determine if [d]{.smallcaps}-amino carboxamides can be stably incorporated into PG during *B. subtilis* growth, we grew cells to early log phase in medium supplemented with 500 μM [d]{.smallcaps}-Phe or [d]{.smallcaps}-Phe-NH~2~ and then analyzed the composition of the pentapeptide in PG fragments following enzymatic degradation. LC/MS analysis showed that [d]{.smallcaps}-Phe and [d]{.smallcaps}-Phe-NH~2~ were incorporated exclusively at the fifth position of the stem peptide, as observed previously for [d]{.smallcaps}-amino acids,^[@ref20]^ but the levels of [d]{.smallcaps}-Phe-NH~2~ were much higher ([Figure S1](#notes-1){ref-type="notes"}). These results led us to examine the utility of fluorescent [d]{.smallcaps}-amino carboxamide probes for imaging cell wall biosynthesis in *B. subtilis*.

We prepared previously reported fluorescent probe **3** (FDL)^[@cit19a]^ as well as new probe **4** (FDL-NH~2~) by appending fluorescein to [d]{.smallcaps}-Lys and [d]{.smallcaps}-Lys carboxamide, respectively (Figure [4](#fig4){ref-type="fig"}a). Wild-type *B. subtilis* (dacA+) was grown in medium supplemented with 100 μM of either **3** or **4** for approximately four generations, and cells were then examined by fluorescence microscopy. FDL-NH~2~**4** efficiently labeled both new septa and the cylindrical walls of the cells. By contrast, FDL **3** inefficiently labeled the cells (Figure [4](#fig4){ref-type="fig"}b). Even FDL-NH~2~ concentrations as low as 10 μM yielded strong labeling ([Figure S2](#notes-1){ref-type="notes"}). Use of the fluorescent carboxamide probe FDL-NH~2~ may be preferable for imaging cell wall synthesis, as it does not require mutations (e.g., *dacA* deletion) that perturb peptidoglycan processing.

To test whether [d]{.smallcaps}-amino carboxamides label PG in *E. coli,* we grew cells to early log phase in medium with 500 μM of either [d]{.smallcaps}-Phe or [d]{.smallcaps}-Phe-NH~2~, harvested the PG, and analyzed the PG fragments using LC/MS as before. As reported previously for [d]{.smallcaps}-amino acids,^[@cit20b],[@ref21]^[d]{.smallcaps}-Phe incorporation was detected exclusively in the fourth position of the stem peptide ([Figure S3b](#notes-1){ref-type="notes"}, trace ii). Strikingly, almost no [d]{.smallcaps}-Phe-NH~2~ incorporation was observed ([Figure S3b](#notes-1){ref-type="notes"}, trace iii). It has previously been suggested that another subset of TPs called the [l,d]{.smallcaps}-transpeptidases are responsible for fourth-position incorporation,^[@cit20b]^ and these data suggest that, like the *E. coli* PBPs, *E. coli*[l,d]{.smallcaps}-transpeptidases discriminate against carboxamides. Likewise, *E. coli* grown with 500 μM of either probe **3** or **4** for four generations incorporated **3** but not **4** ([Figure S4](#notes-1){ref-type="notes"}), indicating that the ability to incorporate [d]{.smallcaps}-amino carboxamides may be specific to organisms like *B. subtilis* that cross-link substrates containing an amino group alpha to a carboxamide.

![Fluorescent [d]{.smallcaps}-amino carboxamide probes dramatically improve detection of PG synthesis. (a) Structures of fluorescent probes. (b) *B. subtilis* was grown with 100 μM probe to mid log phase. Images were adjusted to the same intensity scale to allow comparison. Scale bars: 1 μm.](ja-2014-05668f_0004){#fig4}

The ability of enzymes from *B. subtilis* to incorporate both [d]{.smallcaps}-amino acids and [d]{.smallcaps}-amino carboxamides suggests that there may be two trajectories for nucleophiles to interact with the *B. subtilis* transpeptidase enzyme--substrate intermediate: one for [d]{.smallcaps}-amino acids, which may constitute the reverse of the activation step in which a [d]{.smallcaps}-amino acid is the leaving group, and the other for forming cross-links to incoming *m*-DAP-NH~2~ side chains as well as [d]{.smallcaps}-amino carboxamides that resemble these side chains. For *E. coli*, the incoming side chain is essentially a [d]{.smallcaps}-amino acid, and other modifications are not well tolerated. The dramatically increased efficiency of incorporation of [d]{.smallcaps}-amino carboxamides in *B. subtilis* cells could be due to more efficient incorporation of this nucleophile, less efficient removal by endogenous PG hydrolases once installed, or both. [d]{.smallcaps}-amino carboxamide probes may also be useful for studying pathogenic bacteria that contain an amidated *m*-DAP residue in their peptidoglycan, such as *Mycobacterium tuberculosis* and *Corynebacterium diphtheriae*.^[@cit19b],[@ref22]^ Using this general strategy, it may be possible to design probes that mimic cross-linking residues for other bacteria.

Experimental procedures, synthesis of substrates and compound analysis, protein purification protocols, and LC/MS analysis of PG polymers. This material is available free of charge via the Internet at <http://pubs.acs.org>.
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